Potent inhibition of diverse Omicron sublineages by SARS-CoV-2 fusion-inhibitory lipopeptides

The emergence and rapid spreading of SARS-CoV-2 variants of concern (VOCs) have posed a great challenge to the efficacy of vaccines and therapeutic antibodies, calling for antivirals that can overcome viral evasion. We recently reported that SARS-CoV-2 fusion-inhibitory lipopeptides, IPB02V3 and IPB...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yuanmei, Hu, Yue, Liu, Nian, Chong, Huihui, He, Yuxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574594/
https://www.ncbi.nlm.nih.gov/pubmed/36265805
http://dx.doi.org/10.1016/j.antiviral.2022.105445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574594/
https://www.ncbi.nlm.nih.gov/pubmed/36265805
http://dx.doi.org/10.1016/j.antiviral.2022.105445

Ejemplares similares